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Cytochrome c oxidase biogenesisDeletion of the yeast mitochondrial gene COX2 encoding subunit 2 (Cox2) of cytochrome c oxidase (CcO) re-
sults in loss of respiration (Δcox2 strain). Supekova et al. (2010) [1] transformed a Δcox2 strain with a vector
expressing Cox2 with a mitochondrial targeting sequence (MTS) and the point mutation W56R (Cox2W56R),
restoring respiratory growth. Here, the CcO carrying the allotopically-expressed Cox2W56R was characterized.
Yeast mitochondria from the wild-type (WT) and the Δcox2+Cox2W56R strains were subjected to Blue
Native electrophoresis. In-gel activity of CcO and spectroscopic quantitation of cytochromes revealed that
only 60% of CcO is present in the complemented strain, and that less CcO is found associated in
supercomplexes as compared to WT. CcOs from the WT and the mutant exhibited similar subunit composi-
tion, although activity was 20–25% lower in the enzyme containing Cox2W56R than in the one with Cox2WT.
Tandem mass spectrometry conﬁrmed that W56 was substituted by R56 in Cox2W56R. In addition, Cox2W56R
exhibited the same N-terminus than Cox2WT, indicating that the MTS of Oxa1 and the leader sequence of
15 residues were removed from Cox2W56R during maturation. Thus, Cox2W56R is identical to Cox2WT except
for the point mutation W56R. Mitochondrial Cox1 synthesis is strongly reduced in Δcox2 mutants, but the
Cox2W56R complemented strain led to full restoration of Cox1 synthesis. We conclude that the
cytosol-synthesized Cox2W56R follows a rate-limiting process of import, maturation or assembly that yields
lower steady-state levels of CcO. Still, the allotopically-expressed Cox2W56R restores CcO activity and allows
mitochondrial Cox1 synthesis to advance at WT levels.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cytochrome c oxidase (complex IV or CcO), is the main ﬁnal accep-
tor of the electron transfer chain in mitochondria, catalyzing oxygen
reduction coupled to proton pumping [2]. It is composed of 10–13
subunits and its biogenesis involves both mitochondrion- and
nucleus-encoded polypeptides [3–6]. In yeast, as in the vast majority
of eukaryotes, the three larger subunits of CcO are encoded in the mi-
tochondrial genes COX1, COX2 and COX3 and the corresponding CcO
subunits are synthesized in the organelle [7], while the eight additional
subunits are nucleus-encoded and therefore synthesized in the cytosol
[8]. Normally, Cox2 is synthesized as a precursor in the mitochondrial
matrix with a 15 amino acid leader sequence [9–11] and co-
translationally inserted in the inner mitochondrial membrane [12] in
a process mediated by the Oxa1 translocase [13–15]. As a ﬁnal step ofética Molecular, Instituto de
México, Apartado Postal 70‐
0; fax: +52 55 5622 5611.
z-Halphen).
l rights reserved.Cox2 biogenesis, the leader sequence of 15 residues is removed by a
protease located in the mitochondrial inter-membrane space (IMS)
[9,11] giving rise to the mature subunit with both N- and C-termini ex-
posed to the IMS.
Allotopic expression refers to the expression from the nucleus of a
gene that normally resides in the mitochondrion [16]; it is considered
the basis for the eventual development of gene therapies to treat
human mitochondrial diseases [17,18]. Allotopic expression requires
targeting of the cytosol-synthesized protein to the mitochondrion, in-
ternalization into the organelle, proteolytic maturation, and function-
al assembly into the corresponding OXPHOS complex. Yeast is an
outstanding model for allotopic expression since the tools for genetic
manipulation in this organism are very accessible [19]. The original
contribution of Banroques et al. [20] used the cytosol-synthesized sol-
uble yeast bI4 maturase to complement the activity of its defective,
mitochondrion intron-encoded counterpart. Other studies pioneered
the allotopic expression of membrane-bound mitochondrial proteins
exhibiting one transmembrane stretch (TMS). A yeast strain with del-
eterious mutations in the mitochondrial ATP8 gene (encoding subunit
Atp8 or A6L of mitochondrial ATP synthase) was complemented with
an ATP8 gene recoded to allow its expression from the nucleus
2129V. Cruz-Torres et al. / Biochimica et Biophysica Acta 1817 (2012) 2128–2139[21,22]. The mitochondrial targeting sequence (MTS) of subunit Atp9
from Neurospora crassa allowed the yeast Atp8 protein to be targeted
to mitochondria, internalized into the organelle, and functionally
integrated into complex V (F1Fo-ATP synthase). The allotopically-
expressed Atp8 subunit restored ATP synthesis to levels similar to
those observed in the wild-type (WT) strain and its association to
the mature ATP synthase complex was unequivocally demonstrated
[23,24].
Recently, Cox2 was allotopically-expressed in a yeast mutant
containing a non-functional COX2 mitochondrial gene (Δcox2 mu-
tant) [1]. Two requirements were fulﬁlled in order to complement a
Δcox2 strain with a cytosol-synthesized Cox2: the addition of the
MTS of either the inner mitochondrial membrane proteins Atp9 or
Oxa1, and the substitution of tryptophan 56 by arginine (W56Rmuta-
tion) in the Cox2 sequence (Cox2W56R). This single point mutation,
identiﬁed after a round of random mutagenesis, was enough to dimin-
ish the mean hydrophobicity of the ﬁrst TMS of COX2W56R to such a
degree that allowed the cytosol-synthesized protein to be imported
into mitochondria. Transformation of the respiratory-deﬁcient mutant
with a vector expressing Cox2W56R allowed the growth of the resulting
Δcox2+Cox2W56R complemented strain in non-fermentable carbon
sources, although only 30–40% of the respiratory capacity of the
WT strain was recovered [1]. This report prompted us to explore
whether the partial recovery of respiratory rate was due to a dimin-
ished activity of CcO carrying the allotopically-expressed Cox2W56R
subunit or whether it could be attributed to lower steady-state
accumulation levels of complex IV. Here, we provide a biochemical
characterization of CcO containing the allotopically-expressed
Cox2W56R subunit and show that this mutant subunit was correctly
processed in mitochondria and was able to restore the mitochondrial
synthesis of Cox1 to levels comparable to the ones found in the WT
strain.
2. Materials and methods
2.1. Gene constructs
The gene encoding COX2 of Saccharomyces cerevisiae, containing
the point mutation W56R, was recoded for expression from the nu-
cleus and a region encoding the MTS of OXA1 was added in the 5′
end, as previously described [1]. The construct was chemically syn-
thesized (GeneScript, Piscataway, NJ, USA) and cloned in the pFL61
vector that contains a phosphoglycerate kinase promoter, a kind gift
from Dr. Patrice Hamel (Ohio University, Columbus, USA). Yeast
cells were transformed in the presence of lithium acetate and salmon
sperm DNA as described [25].
2.2. Strains, culture conditions, and isolation of yeast mitochondria
S. cerevisiae strains used in this study were NB40-36A (MATα, lys2,
arg8::hisG, ura3-52, leu2-3, 112, [rho+]) and NAB97 (MATa, lys2,
arg8::hisG, ura3-52, leu2-3, 112, his3-deltaHindIII, ydr494wHA, cox2-
22, [rho+]). The strains were a kind gift from Prof. Thomas Fox,
Cornell University (USA). Cells were grown in fermentable medium
YPD (1% yeast extract, 2% bactopeptone, and 2% glucose). Non-
fermentable media were lactate medium (3 g yeast extract, 1 g KH2PO4,
1 g NH4Cl, 0.5 g CaCl2·H2O, 0.5 g NaCl, and 1.1 g MgSO4·7H2O, 0.3 ml
of a 1% FeCl3 solution and 22 ml 90% lactate) [26] and YPEG (1% yeast ex-
tract, 2% bacto-peptone, 3% ethanol and 3% glycerol). Minimal medium
(0.17% yeast nitrogen base without amino acids) was supplemented
with 2% glucose, rafﬁnose or galactose and speciﬁc amino acids. All cells
were grown at 160 rpm in aNewBrunswick shaker in a constant temper-
ature room at 30 °C for 15 h and were harvested at the logarithmic
growth phase. Cells were washed with water and resuspended in ex-
traction buffer (0.6 M mannitol, 10 mM maleic acid and 0.1% BSA,
pH 6.8 adjusted with triethanolamine) and disrupted using a BeadBeater cell homogenizer (Biospec Products) with 0.45 mm glass beads
(3×20 secondpulses separated by 40 second resting periods). To isolate
mitochondria, the homogenate was differentially centrifuged as de-
scribed [27] and protein concentration was determined by biuret [28].
Mitochondria were frozen and stored at−70 °C for further use.
2.3. Isolation of CcO and enzymatic activities in chromatography eluates
CcO was isolated following a protocol previously described for the
algal enzyme [29]. Brieﬂy, yeast mitochondria were solubilized with
2 g of n-dodecyl-beta-D-maltoside (LM) per g of protein at a
protein concentration of 10 mg/ml in 1 mM MgSO4, 1 mM phenyl-
methyl-sulfonyl ﬂuoride (PMSF), 50 mM Tris, pH 8.0, plus 50 μg of
N-alpha-tosyl-L-lysyl-chloromethyl-ketone (TLCK) mL−1. The ex-
tract was centrifuged at 100,000 ×g for 30 min and layered on top
of a DEAE-Biogel A column. The column was washed with 3 volumes
of 50 mM Tris, 1 mM MgSO4 and proteins were eluted with a
0–200 mM NaCl gradient (two column volumes) and washed with
200 mM NaCl (1 column volume). In this wash a fraction enriched
in CcO was recovered. In addition, a crude fraction of bc1 complex
was also recovered after eluting the column with 400 mM NaCl in
the same buffer. Fractions (2.5 ml) were collected and the protein con-
tent of each fraction was estimated spectrophotometrically at 280 nm.
Twentymicroliters of each fractionwere collected in a well of a 96-well
plate and CcO activity in the fractions was assayed in the presence of
50 mM phosphate buffer (sodium) pH 7.4, 2.5 mg·mL−1 horse-heart
cytochrome c, and 1 mg·mL−1 diaminobenzidine [30]. Absorbance at
490 nm was quantitated in a multimodal micro plate reader Synergy
Mix (Biotek). The fractions enriched in CcO were recovered and con-
centrated by ultraﬁltration in a YM100 membrane (Amicon). After
adding glycerol to a ﬁnal concentration of 10%, the sample was loaded
onto 15 to 40% glycerol gradients in 20 mM Tris–HCl (pH 8.0), 1 mM
sodium EDTA, and 0.1 mg/ml of LM. The gradients were centrifuged
at 40,000 ×g for 17 h in a swing out rotor. Protein concentrations
were determined as previously described [31].
2.4. Cytochrome measurements using differential spectrophotometry
Mitochondria were solubilized with LM (2 mg of detergent per mg of
protein) and centrifuged at 100,000 ×g for 30 min. Absorbance spectra
were recorded from 500 to 680 nm in a DW2000 Aminco spectropho-
tometer in the presence of ferricyanide to obtain the oxidized spectra,
which was assigned as baseline. Then, the reduced spectrum was re-
corded after addition of sodiumdithionite to the sample cuvette. Differen-
tial absorption coefﬁcients (reducedminus oxidized)were: for bothhorse
heart and yeast soluble cytochrome c (550–540 nm) 19.5 mM−1 cm−1
[32], for cytochrome b (560–575 nm) 25.0 mM−1 cm−1 [32], for cyto-
chromes aa3 (603–630 nm) 16.5 mM−1 cm−1 [33], and for cytochrome
c1 (553–541 nm) 17.5 mM−1 cm−1 [34].
2.5. Oxygen uptake measurements
The rate of oxygen consumption was measured in an oxygen
meter model 782 (Warner/Strathkelvin Instruments) with a Clark
type electrode in a 0.1 mL water-jacketed chamber at 30 °C [35]
and data were analyzed using the 782 Oxygen System software
(Warner/Strathkelvin Instruments). The assay contained 50 mM
Hepes pH 7.4, 0.1% LM, 10 mM ascorbate, 200 μM tetramethyl-
para-phenylenediamine (TMPD), 50 nM CcO and 50 μM horse heart
cytochrome c or yeast cytochrome c as indicated. When needed,
100 μM KCN was added to inhibit CcO activity.
2.6. Gel electrophoresis and in-gel enzymatic activities
Denaturing gel electrophoresis was carried in a SDS-tricine-PAGE
system [36], or when indicated, in a SDS-glycine-PAGE system [37].
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sis (BN-PAGE) were carried out as described [38]. Brieﬂy, mitochon-
dria were washed in 250 mM sorbitol, 50 mM Bis-Tris (pH 7.0), and
centrifuged at 12,000 ×g for 10 min at 4 °C. The pellet was
resuspended in sample buffer [750 mM aminocaproic acid, 50 mM
Bis-Tris (pH 7.0)] and solubilized with 2.0 g LM per g of protein (1%
LM) for 30 min and centrifuged at 100,000 ×g at 4 °C for 30 min.
When indicated, mitochondria were solubilized in the same sample
buffer but in the presence of 4.0 g digitonin per g of protein (2% dig-
itonin). The supernatants (1 mg protein) were loaded on 5–15% poly-
acrylamide gradient gels. The stacking gel contained 4% (w/v)
polyacrylamide. In-gel CcO activity was determined using 3, 3′‐
diaminobenzidine and cytochrome c as described [39,40]. In-gel
ATPase activity was visualized after BN-PAGE [41,42]. The gels were
incubated for 3 h in a buffer containing 270 mM glycine and 35 mM
Tris–HCl (pH 8.4). Then, the following additions were made: 8 mM
ATP, 14 mM MgSO4, and 0.2% Pb(NO3)2. Once the white precipitates
of lead phosphate became visible, the reaction was stopped with
50% methanol.
2.7. Immunoassays
From BN- or SDS-tricine-PAGE, proteins were electro-transferred
onto a nitrocellulose Trans-Blot membrane (BioRad) for immune-
detection [43]. Membranes were washed, blocked, and incubated
with the following monoclonal antibodies (Invitrogen; Molecular
Probes) anti-human Cox1 (1:3000 for 8–12 h), anti-yeast Cox2
(1:3000 for 8 h), or anti-yeast Cox3 (1:3000 for 8–12 h) using an al-
kaline phosphatase-conjugated anti-mouse IgG (1:3000 for 2 h) as
secondary antibody. When Western blots were carried out with
anti-citrate synthase (1:1000 for 1 h) or anti-bovine Rieske iron–
sulfur protein (1:5000 for 8 h), the secondary antibody used was an
alkaline phosphatase-conjugated anti-rabbit IgG (1:3000 for 2 h). Be-
fore carrying a second Western blot reaction with a different primary
antibody, the membrane was incubated for 30 min at 60 °C in
the presence of 2% SDS, 62.5 mM Tris–HCl pH 6.8 and 100 mM
β-mercapto-ethanol. The anti-citrate synthase antibody was a kind
gift from Prof. Thomas Fox, Cornell University (USA).
2.8. Analysis of mitochondrial protein synthesis
In vivo pulse-chase labeling of cells with [35S] methionine in the
presence of cycloheximide was performed as described [44], except
that cells were grown initially in minimal medium with 2% rafﬁnose,
and previous to labeling, cells were transferred to a medium lacking
methionine for 30 min. Then, cells were labeled with 15 μCi of [35S]
methionine for 15 min, were washed with a buffer containing 0.6 M
sorbitol and 20 mM Hepes pH 7.4, and then chased with cold
10 mM methionine for 1 to 4 h at 30 °C. After labeling, cells were
incubated in ice and disrupted with glass beads in order to isolate
mitochondria [45]. The radiolabeled mitochondrion-synthesized
polypeptides were subjected to SDS-glycine-PAGE on a 16% poly-
acrylamide gel [37]. The gel was dried and analyzed in a Typhoon
8600 Phosphorimager (GE Healthcare).
2.9. N-terminal sequencing
The isolation of polypeptides for N-terminal sequencing was carried
out as previously described [46]. The polypeptides of CcO were resolved
by SDS-tricine-PAGE, transferred to a PVDF membrane, stained with
Coomassie Brilliant Blue and the bands that corresponded to Cox2 were
carefully excised from the membrane. N-terminal sequencing by auto-
mated Edman degradation of Cox2 was carried out by Dr. J. d'Alayer on
an Applied Biosystems Sequencer at the Laboratoire deMicroséquençage
des Protéines, Institut Pasteur, Paris (France).2.10. Tandem mass spectrometry (LC/ESI–MS/MS)
2.10.1. Sample preparation
After SDS-tricine-PAGE, the protein bands were excised from the
Coomassie stained gel and destained with 50% (v/v) methanol 5%
(v/v) acetic acid for 12 h. The destained gels were washed with de-
ionized water, soaked for 10 min in 100 mM ammonium bicarbonate,
cut into small pieces, dehydrated with 100% acetonitrile and vacuum-
dried. Proteins were reduced with 10 mM DTT and S-alkylated cyste-
ine with 100 mM iodoacetamide in 100 mM ammonium bicarbonate.
In gel digestion was performed by adding 30 μL of modiﬁed porcine
trypsin solution (20 ng/μL) in 50 mM ammonium bicarbonate
followed by overnight incubation at room temperature. Peptides
were extracted with 50% (v/v) acetonitrile 5% (v/v) formic acid
twice for 30 min each time with sonication. The extracts were dried
down under vacuum and resuspended in 20 μL of 0.1% formic acid.
2.10.2. LC/MS/MS
HPLC/MS/MS analysis of peptides was carried out using an inte-
grated nano-LC_ESI_MS/MS system. A NanoAcquity ultraperformance
liquid chromatograph (UPLC) (Waters Corporation) coupled to a Q-ToF
Synapt G2 high deﬁnition mass spectrometer (Waters Corporation)
equipped with a NanoLockSpray ion source. The mass spectrometer
was calibrated with a NaCI solution (mass range: 50 to 2000 Da)
and operated in ESI positive V-mode at a resolution of 10,000 full
width at half height (fwhh). Spectra were acquired in automated
mode using data-dependent acquisition (DDA). [Glu 1] ﬁbrinopeptide
B solution (100 fmol/μL) was infused through the reference sprayer
of the NanoLockSpray source at a ﬂow rate of 0.5 μL/min and was
sampled at 30 s intervals during the acquisition. MS survey scans of
1 s over the m/z range 300 to 1600 were used for peptide detection
followed by two MS/MS scans of 2 s each (m/z 50 to 2000) of
detected precursors. Collision energies were automatically adjusted
based upon the ion charge state and the mass. The ﬁve most intensive
precursor ions of charge 2+, 3+ or 4+ were interrogated per MS/MS
switching event. Dynamic exclusion for 60 s was used to minimize
multiple MS/MS events for the same precursor. The data were
postacquisition lock mass corrected using the doubly protonated
monoisotopic ion of [Glu 1] ﬁbrinopeptide.
2.10.3. Data processing and protein identiﬁcation
DDA raw data ﬁles were processed and searched using the
ProteinLynx Global Server version 2.4 (PLGS) software (Waters
Corporation).The default parameter settings included: Perform
lockspray calibration with a lockmass tolerance of 0.1 Da. Background
subtract type, adaptative. Deisotoping type, medium. The processed
DDA was queried against the S. cerevisiae database (http://www.
Uniprot.org/) appended with the Cox2W56R sequence. Trypsin was
set as the digest reagent and one missed cleavage site was allowed.
Mass tolerances of 30 ppm and 0.05 Da were used for precursor and
product ions, respectively. Carbamidomethyl-cysteine was the ﬁxed
modiﬁcation. Met oxidation and Gln–Asn deamidation were set as
variable modiﬁcations.
2.11. In silico protein analysis
The sequences of yeast CcO subunits were modeled with
SwissModel (http://swissmodel.expasy.org/) [47–49] using as template
bovine heart cytochrome c oxidase at the fully oxidized state (PDB ID:
2OCC) [50]. Models were made in Automated Mode, except for the
one of Cox7a, which was done in Alignment Mode. The following
yeast sequences were modeled upon their corresponding templates:
Cox1 encoded by COX1 (NCBI accession number NP_009305) on PDB
ID: 2occA; Cox2 encoded by COX2 (NP_009326) on PDB ID: 2occB;
Cox3 encoded by COX3 (NP_009328) on PDB ID: 2occC; Cox4 encoded
by COX4 (NP_011328) on PDB ID: 2occF; Cox5 encoded by COX5
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on PDB ID: 2occE; Cox7 encoded by COX7 (NP_013983) on PDB ID:
2occJ; Cox8 encoded by COX8 (NP_013499) on PDB ID: 2occL; Cox7a
encoded by COX9 (NP_010216) on PDB ID: 2occI; Cox9 encoded by
COX12 (NP_013139) on PDB ID: 2occH; and Cox13 encoded by COX13
(NP_011324) on PDB ID: 2occG. Models were visualized with Swiss-
PdbViewer 4.0.4. The nomenclature of yeast CcO subunits is in accor-
dance with Barrientos et al. [51].3. Results
3.1. Complementation of a respiratory mutant defective in the gene COX2
by an allotopically expressed Cox2W56R
Yeast mutants carrying a defective mitochondrial COX2 gene
(Δcox2) are unable to grow in non-fermentable carbon sources [52].
The Δcox2 yeast mutant used in this work grew in fermentable carbon
sources including glucose, galactose and rafﬁnose (Fig. 1A, upper
panels), but as expected, failed to grow in the presence of non-
fermentable carbon sources like lactate or amixture or ethanol–glycerol
(Fig. 1A, lower panels). In contrast, theWT strain grew in both ferment-
able andnon-fermentable carbon sources, (Fig. 1A, all panels). The yeast
mitochondrial COX2 gene was recoded and cloned into an expression
vector, giving rise to the Cox2W56R precursor containing the MTS of
Oxa1, the natural 15 amino acid leader sequence of Cox2 and the
W56R mutation described earlier [1]. The Δcox2 mutant was trans-
formed with this construct, and the resulting transformants were chal-
lenged to grow on non-fermentable carbon sources. In solid media, the
complemented strain (Δcox2+Cox2W56R transformant) grew faster inesoculg
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Fig. 1. Cells carrying the allotopically-expressed Cox2W56R subunit grow in non-fermentab
carbon sources. Wild-type (WT), the Δcox2 mutant (Δcox2) and the Δcox2+Cox2W56R tran
carbon sources glucose, galactose, or rafﬁnose (upper panels) and the non-fermentable carb
at 30 °C, except for the panel of ethanol plus glycerol that corresponds to 4 days of growth. B
sources. Optical density at 600 nm was measured at the indicated times for the WT strain (lactate than in ethanol and glycerol, albeit in both cases, at lower rates
as compared to the WT strain (Fig. 1A, lower panels). The growth of
the Δcox2+Cox2W56R transformant was also slower than that of the
WT strain in liquid media containing ethanol and glycerol (Fig. 1B). Es-
timated generation timeswere 5.4 forWT and 6.7 forΔcox2+Cox2W56R
in ethanol–glycerol; and 5.0 for WT and 6.1 for Δcox2+Cox2W56R in
lactate medium.
To identify the presence of Cox2 in the different strains, yeast was
grown in a galactose medium and whole cell protein extracts were
loaded onto gels to perform SDS-tricine-PAGE. Then, Western blot
analysis was carried out using speciﬁc anti-yeast Cox2 antibodies.
Fig. 2A shows the presence of mature Cox2 in whole cell protein ex-
tracts from the WT strain (mCox2WT; Fig. 2A lane 1), from the
Δcox2+Cox2W56R transformant (mCox2W56R; Fig. 2A lane 4), from iso-
lated mitochondria from the WT strain (Fig. 2A, lane 5), and from a
crude fraction of isolated bc1 complex (Fig. 2A, lane 6). In contrast, in
the Δcox2 mutant (Fig. 2A, lane 2) and the Δcox2 mutant transformed
with an empty vector (Fig. 2A, lane 3) no Cox2 band was observed. A
second band with a higher molecular mass, representing the
Cox2W56R precursor protein (pCox2W56R), was present only in the
whole cell protein extract of the Δcox2+Cox2W56R transformant
(Fig. 2A, lane 4). The nylon membrane was stripped and re-decorated
with an anti-Rieske iron sulfur protein antibody (anti-FeS). Both the
WT strain and the Δcox2+Cox2W56R transformant exhibited equiva-
lent amounts of the bc1 complex subunit.
In order to isolate mitochondria, colonies from the WT strain and the
Δcox2+Cox2W56R transformant were selected and grown in a medium
containing galactose as carbon source. To search for the presence of
Cox2W56R subunits, mitochondria were isolated, solubilized, and
subjected to SDS-tricine-PAGE and Western blot analysis. Fig. 2B showsesoniffargalactose
lactate
WT 
Δcox2+Cox2 W56R
20 25 30
h)
le carbon sources. A) Growth of the yeast strains on solid media containing different
sformant were serially diluted and spotted on solid media containing the fermentable
on sources ethanol plus glycerol or lactate (lower panels). Cells were grown for 3 days
) Growth of the yeast strains in liquid media containing ethanol and glycerol as carbon
black circles) and the Δcox2+Cox2W56R transformant (open circles).
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Fig. 2. The mature Cox2W56R is present in whole cell protein extracts and in mitochondria, albeit at lower levels than Cox2WT. A) Western blot of whole yeast protein extracts show-
ing the presence or absence of the Cox2 subunit in the WT strain (lane 1), in the Δcox2mutant (Δcox2, lane 2), in a Δcox2mutant transformed with empty-plasmid (Δcox2+vector,
lane 3), in the Δcox2+Cox2W56R transformant (lane 4), in isolated mitochondria fromWT (lane 5), and in a crude preparation of isolated bc1 complex (lane 6). The resulting mature
proteins are marked as mCox2WT and mCox2W56R, while the allotopically-expressed precursor containing the MTS and the 15-residue leader sequence is denoted by pCox2W56R.
B) Western blot analysis of yeast mitochondria isolated from the WT strain (lane 1), the Δcox2 mutant (Δcox2, lane 2), the Δcox2 mutant transformed with empty-plasmid
(Δcox2+vector, lane 3), and the Δcox2+Cox2W56R transformant (lane 4). The blot was decorated with an anti-Cox2 antibody. For loading controls the membrane was reblotted
with an antibody directed against citrate synthase (CS). C) A Western blot similar to the one shown in panel B was decorated with anti-Cox2 antibodies and reblotted with anti-
bodies raised against the bovine Rieske-type iron sulfur protein of the bc1 complex (FeS).
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WT strain (mCox2WT; Fig. 2B lane 1) and from the Δcox2+Cox2W56R
transformant (mCox2W56R; Fig. 2B lane 4). No Cox2 band was observed
in the Δcox2mutant (Fig. 2B, lane 2) or in the Δcox2mutant transformed
with an empty vector (Fig. 2B, lane 3). The Cox2W56R precursor protein
(pCox2W56R), was present only inmitochondria of theΔcox2+Cox2W56R
transformant (Fig. 2B, lane 4), suggesting that a fraction of this precursor
may have been internalized into the organelle. To ensure that equivalent
amounts of mitochondrial protein were loaded in the blot, the nylon
membrane was re-blotted with antibodies raised against citrate synthase
(CS). As judged by the immunochemical reaction, equivalent amounts of
CS seem to be present in all the analyzedmitochondrial fractions (Fig. 2B,lanes 1–4). The ratio of mCox2WT to CS, as judged by densitometry was
3.65 (Fig. 2B, lane 1), while the ratio of mCOX2W56R to CS was 1.60
(Fig. 2B, lane 4), indicating that the mature form of the cytosol-
synthesized Cox2W56R was only a fraction of the mitochondrion-
synthesized Cox2WT. A parallel blot, decorated with antibodies against
the Cox2 subunits and against the bovine Rieske iron sulfur protein of
the bc1 complex revealed similar results (Fig. 2C, lanes 1–4).
3.2. Resolution of complex IV by Blue-Native gel electrophoresis
BN-PAGE allows to separate and to visualize membrane com-
plexes under native conditions [53] and has been a powerful tool to
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contents among theWT, the Δcox2mutant and the Δcox2+Cox2W56R
transformant, the strains were grown in a rafﬁnose-containing medi-
um. Mitochondria were isolated, solubilized with LM and subjected to
BN-PAGE. Fig. 3A shows the polypeptide pattern of the mitochondrial
complexes as obtained after BN-PAGE (Fig. 3A, lanes 1–3), and after
ﬁxing and staining with Coomassie Brilliant Blue (Fig. 3A, lanes
4–6). In-gel activity staining was carried out in order to identify
some of the main mitochondrial complexes. To localize the active
yeast F1Fo-ATPase (complex V) on BN-PAGE, duplicate lanes were in-
cubated in the presence of ATP and Pb(NO3)2. A band of 540 kDa was
able to hydrolyze ATP, as indicated by the formation of a lead phos-
phate precipitate (Fig. 3A, lanes 7–9). All mitochondria, including
the Δcox2 mutant, exhibited equivalent amounts of complex V as
judged by Coomassie Blue staining (Fig. 3A, lanes 4–6), and in-gel ac-
tivities (Fig. 3A, lanes 7–9). When in-gel staining was carried out for
CcO activity, two close bands revealed activity in the WT and in the
Δcox2+Cox2W56R strains (Fig. 3A, lanes 10 and 12), while no in-gel
activity could be detected in the Δcox2 mutant, as expected (Fig. 3A,
lane 11). Two close bands exhibiting CcO activity after BN-PAGE
have been previously described in yeast mitochondria. The upper
band probably corresponds to the monomeric holoenzyme CcO com-
plex, while the lower one represents a CcO lacking subunit Cox6
(equivalent to bovine subunit Cox6a) that may partially dissociate
during BN-PAGE [52]. The Δcox2+Cox2W56R transformant exhibited
in-gel CcO activity, albeit with 40% lower intensity than the one ob-
served for the WT, as judged by densitometry. The lower activity of
CcO could be attributed either to a lower enzymatic activity or to
lower steady-state accumulation levels of complex IV.
In order to estimate the ratio of CcO to cytochrome bc1 complex in
the WT strain and in the Δcox2+Cox2W56R transformant, the content
of aa3-type hemes and b-type hemes were determined from reduced
minus oxidized difference spectra (Fig. 3B). For this purpose, mitochon-
dria from WT and the Δcox2+Cox2W56R transformant grown in a lac-
tate liquid medium and mitochondria from the Δcox2 mutant grownin galactose were solubilized with LM, centrifuged, and difference spec-
tra of the supernatants were recorded (dithionite-reduced minus
ferricyanide-oxidized). As expected, mitochondria from the Δcox2mu-
tant exhibited undetectable levels of type aa3 hemes and it also
exhibited diminished levels of bc1 complex (160 pmoles of heme b
per mg of protein). In contrast, the WT strain exhibited 266 pmoles of
heme aa3 per mg of protein, and the Δcox2+Cox2W56R transformant
154 pmoles of heme aa3 per mg of protein. The heme aa3/heme b ratios
obtainedwere 0.75 for theWT strain and 0.30 for theΔcox2+Cox2W56R
transformant. Since both yeast strains contained similar amounts of bc1
complex (354 and 396 pmoles of b heme per mg of protein, respective-
ly), these data further supports the observation that there is approxi-
mately 40% less steady-state accumulation levels of CcO in the
allotopically-transformed strain as compared to the WT strain.
We asked whether partially-assembled CcO sub-complexes were
present in the Δcox2+Cox2W56R transformant. For this purpose, mito-
chondria were isolated, solubilized with LM, subjected to BN-PAGE
followed by second-dimension denaturing SDS-tricine-PAGE, trans-
ferred to a PVDF membrane and assayed by Western blotting using an
anti-Cox3 antibody. No CcO sub-complex, at least no one containing
Cox3, could be detected (Fig. 3C).
Since only 60% of assembled CcO is present in the Δcox2+Cox2W56R
transformant as compared to theWT strain, we thought of interest to ex-
plore the amount of supercomplexes present in both strains. For this pur-
pose, mitochondria solubilized with 2% digitonin were subjected to BN-
PAGE. Fig. 3D shows the polypeptide pattern of the mitochondrial
supercomplexes as obtained after BN-PAGEand in-gel staining for CcO ac-
tivity (Fig. 3D, lanes 1–4). Four main bands exhibited in-gel CcO activity
that were attributed to monomeric complex IV, dimeric complex IV
(IV2), and to two supercomplexes formed by the association of CcO and
bc1 complex (III2IV1 and III2IV2) (Fig. 3D, lanes 1 and 2). The in-gel CcO ac-
tivity after digitonin solubilization was considerably higher than the one
observed after LM solubilization (Fig. 3A, lanes 10 and 12), but was
completely sensitive to cyanide (Fig. 3D, lanes 3 and 4). Nevertheless, in
gel-staining of CcO activity of the Δcox2+Cox2W56R transformant was
Fig. 5. The W56R mutation in Cox2 is present in the assembled CcO carrying the allotopicaly-expressed Cox2W56R. Coverage maps showing the polypeptides derived from mature
Cox2WT and Cox2W56R identiﬁed by MS/MS after trypsin degradation. Arrows indicate possible trypsin cleavage sites, double underlined sequences indicate the polypeptides iden-
tiﬁed by MS/MS, W56 and R56 denote the residues involved in the W56R point mutation. These residues are actually located in position 41 of the sequence of the mature Cox2
subunit starting DVPTPPY. The gray box indicates the polypeptide generated by the presence of R56 in the mutant Cox2.
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analysis. Decrease of the in-gel CcO activity in the Δcox2+Cox2W56R
transformant was especially notable in the III2IV1 and III2IV2
supercomplexes, indicating a lower accumulation of supercomplexes
when the amounts of CcO are limiting. In order to ascertain the presence
of less supercomplexes in theΔcox2+Cox2W56R transformant, equivalent
lanes of digitonin-solubilized mitochondria were subjected to BN-PAGEFig. 6. Synthesis of Cox1 has normal levels in the Cox2W56R strain and is stable for at least 4
(with empty vector; lanes 6–10) and the Δcox2+Cox2W56R transformant (lanes 11–15) we
analyzed as described under Materials and methods. The identity of each polypeptide is label
1, 2, 3 and 4 h as indicated. Labeled translation products are indicated as follows: cytochr
subunit 6 of ATPase, Atp6; subunit 8, Atp8; subunit 9, Atp9; and the ribosomal protein, Va
to the neo-formed c-ring (Atp9 oligomer) was observed with less intensity in the Δcox2+followed by denaturing 2D-SDS-PAGE and Western blotting using anti-
Cox3 and anti-FeS antibodies. Less Cox3 antibody staining was found
associated to the III2IV1 and III2IV2 supercomplexes in the Δcox2+
Cox2W56R transformant as compared to the WT strain. In addition,
while all the bc1 complex of the WT strain was found associated to CcO
in the III2IV1 and III2IV2 supercomplexes, the presence of free, monomeric
bc1 complex (III2) could be detected only in the Δcox2+Cox2W56R strainh. Mitochondrial translation products of the WT strain (lanes 1–5), the Δcox2 mutant
re labeled with [35S] methionine in the presence of cycloheximide, and proteins were
ed. The different strains were pulsed with [35S] methionine for 15 min and chased for 0,
ome c oxidase subunit 1, Cox1; subunit 2, Cox2; subunit 3, Cox3; cytochrome b, Cob;
r1. For unknown reasons, in this particular experiment the upper band corresponding
Cox2W56R transformant.
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supercomplexes containing CcO are accumulated in the Δcox2+
Cox2W56R transformant.3.3. Isolation and partial characterization of CcO from WT and the
Δcox2+Cox2W56R yeast strains
Complex IV was puriﬁed from both the WT (CcOWT) and the mu-
tant (CcOW56R) mitochondria. The isolated complexes catalyzed elec-
tron transfer from yeast cytochrome c to oxygen in a fully
cyanide-sensitive reaction. The speciﬁc activities of oxygen uptake
measured in the presence of 100 μM reduced yeast cytochrome c
were 6.4 and 4.8 ngat O/nmol aa3/min for the CcOWT and the
CcOW56R respectively. Higher rates of oxygen uptake were observed
in the presence of 100 μM reduced horse heart cytochrome c, 9.2
and 7.4 ngat O/nmol aa3/min for the CcOWT and the CcOW56R respec-
tively. This data indicate that the CcOW56R exhibits 75 to 80% of the
activity of the CcOWT enzyme. Fig. 4A (lanes 1 and 2) shows the poly-
peptide pattern after SDS-tricine-PAGE of the isolated enzymes. Both
CcO exhibited similar polypeptide compositions. To conﬁrm the iden-
tity of the three main polypeptides, Cox1, Cox2 and Cox3, Western
blot analysis using speciﬁc antibodies against these subunits was car-
ried out (Fig. 4B, lanes 3–8). The antibodies recognized all three sub-
units both in the CcOWT (Fig. 4B, lanes 3, 5 and 7) and in the CcOW56R
(Fig. 4B, lanes 4, 6 and 8). Thus, the bands corresponding to Cox2WT
and Cox2W56R were unambiguously identiﬁed and used in further
analyses.
To conﬁrm the presence of the substitution of residue W56 by R56
in the sequence of the Cox2W56R subunit, both the Cox2WT and the
Cox2W56R polypeptides were excised from the gel and subjected
to trypsin digestion, and thereafter analyzed by tandem mass spec-
trometry (MS/MS). The identiﬁed peptides are shown in the coverage
maps of Fig. 5. The polypeptide MLYTIVMTY was present in the tryp-
sin digestion pattern of Cox2W56R, while it was absent in the digestion
pattern of Cox2WT, strongly suggesting the presence of residue R56 in
the Cox2W56R subunit. The presence of R56 generates a new cleavage
site for trypsin in Cox2W56R that gives rise to the abovementioned
polypeptide. Thus, unequivocal evidence is provided that the
cytosol-synthesized Cox2W56R was found as a subunit assembled
into CcO.
The mitochondrion-encoded Cox2 of S. cerevisiae is normally syn-
thesized inside the organelle as a precursor containing an N-terminalbi
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IMS
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Fig. 7. Yeast CcO subunits modeled on the bovine CcO crystallographic structure. A) Model
proximity to L24 (green) of Cox7a (magenta). The rest of the subunits are depicted in lightleader sequence of 15 residues [9,11]. The allotopically-expressed
Cox2W56R precursor, besides theMTS of Oxa1, also contains this natural
leader sequence of 15-residues. Since the Cox2W56R that was imported
into mitochondria and assembled into CcO exhibited an apparent mo-
lecular mass identical to Cox2WT, it was expected that both protein pre-
cursors eventually gave rise to the same mature protein. Both Cox2WT
and Cox2W56R polypeptides were transferred onto a PVDF membrane
and subjected to N-terminal sequencing by Edman degradation. The
ﬁrst ten residues of the N-terminal sequence obtained for Cox2W56R
(DVPTPYACYF) were identical to the ones obtained for the Cox2WT
(DVPTPYACYFQD). Therefore, mitochondrion-synthesized Cox2WT is
proteolitically processed once by removal of its 15-residues leader se-
quence, while the allotopically-expressed Cox2W56R precursor must
be proteolitically processed twice, ﬁrst by the removal of the MTS
from Oxa1, then by the removal of the 15-residue leader sequence.
Most probably, removal of the MTS occurs in the mitochondrial matrix,
while the processing of the leader sequence should take place in the
mitochondrial inter-membrane space [11,55]. These data led us to con-
clude that Cox2W56R is structurally identical to Cox2WT. Since theW56R
mutation seems to only slightly impair CcO activity, it can also be con-
cluded that the lower respiratory activity of the Δcox2+Cox2W56R
transformant is mainly due to the presence of lower steady-state levels
of assembled complex IV. Therefore, the import, maturation, or assem-
bly of the allotopically-expressed Cox2W56R must be the limiting step of
complex IV biogenesis in the Δcox2+Cox2W56R transformant.3.4. Regulation of Cox1 biogenesis by the presence of an allotopically-
expressed Cox2W56R
In vivo or in-organello pulse labeling of Cox1 with [35S] methionine
is strongly reduced in the presence of mutations that block CcO as-
sembly. This reduced labeling of Cox1 is due to a decrease in Cox1
synthesis [6]. Thus, absence of mitochondrial Cox2 synthesis is one
of the multiple factors that down-regulates Cox1 biogenesis. We
asked whether the allotopically-expressed Cox2W56R would restore
mitochondrial Cox1 synthesis; thus indicating a normal CcO assem-
bly. In vivo pulse labeling of yeast with [35S] methionine in the pres-
ence of cycloheximide was performed, followed by SDS-glycine-
PAGE and analysis of the radioactive label. The synthesis of Cox1
was severely diminished in the Δcox2 mutant as compared to the
WT strain (Fig. 6, lanes 1 and 6). As expected, no band that would in-
dicate Cox2WT synthesis was observed in the Δcox2 mutant (Fig. 6,Cox2
Cox7a
W56
L24
R56
showing the position of residues W56 (cyan) and R56 (blue) in Cox2 (red) and its close
gray.
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teins in the Δcox2+Cox2W56R transformant also exhibited the ab-
sence of a mitochondrion-synthesized Cox2WT band as expected
(Fig. 6, lane 11). Nevertheless, Cox1 synthesis in the Δcox2+
Cox2W56R transformant was equivalent to the one observed in the
WT strain (Fig. 6, lanes 1 and 11). Thus, the presence of the
allotopically-expressed Cox2W56R protein in mitochondria, allows
Cox1 biosynthesis to be restored to levels equivalent to those found
in the WT strain. Furthermore, a pulse-chase experiment showed
that both the Cox1 subunit synthesized by the WT and by the
Δcox2+Cox2W56R transformant were stable for as long as 4 h
(Fig. 6, lanes 2–5 and 12–15 respectively), suggesting that Cox1 is
being incorporated correctly into CcO in both strains.
4. Discussion
In yeast, as in the vast majority of eukaryotes, Cox2 is encoded in
themitochondrial genome. However, in some species themitochondri-
al gene COX2 has naturally migrated to the nucleus, either as an intact
gene (as in legumes) [56] or as split genes (as in green algae and
apicomplexan parasites) [57–59]. Efforts have been made to emulate
the natural migration of mitochondrial genes to the nucleus by engi-
neering the corresponding mitochondrial COX2 gene to allow its ex-
pression from the nucleus, the so called allotopic expression. Daley et
al. [60] were able to internalize in vitro synthesized soybean Cox2 car-
rying two point mutations into isolated soybean mitochondria. More
recently Supekova et al. [1] expressed a Cox2W56R precursor in vivo,
successfully restoring respiration in a Δcox2 yeast mutant. Several
modiﬁcations must be made on the original mitochondrial genes to
allow its allotopic expression. The mitochondrial gene sequence must
be recoded in accordance with the nuclear genetic code and with its
codon usage bias, and a nucleotide sequence encoding an appropriate
MTS must be added, in order to ensure correct delivery of the
cytosol-synthesized protein tomitochondria. Diminished hydrophobic-
ity seems also to be a key feature to allow import of mitochondrial
membrane proteins whose genes naturally migrated to the nucleus or
that they were engineered to be synthesized in the cytosol [60–66].
For example, the nucleus-encoded subunits Cox2A, Cox2B, Cox3,
Atp6, Nad3 and Nad4L of chlorophycean algae exhibit reduced
hydrophobicity compared to their mtDNA-encoded counterparts
[29,57,58,67]. For algal Cox3 and Atp6, the decrease of mean hydropho-
bicity occurs mostly in those TMS that are not crucial for function or
that are not involved in subunit-subunit interactions [29,58,68]. A sim-
ilar observation was made with the mitochondrial sdh3 gene, encoding
a succinate dehydrogenase (complex II) subunit, relocated to the nu-
cleus in angiosperms; its protein product also exhibits a diminished hy-
drophobicity when compared to its mitochondrial counterparts [69].
Also, in leguminous species that express bothmitochondrial and nucle-
ar COX2 genes, the nucleus-encoded Cox2 proteins exhibit a lower hy-
drophobicity than their mitochondrion-encoded counterparts. It was
clearly demonstrated that two amino acid changes in the ﬁrst TMS of
soybean Cox2 that introduced less hydrophobic residues, were neces-
sary to allow the in vitro import of the protein by isolated mitochondria
[60]. Also, the W56R mutation, that diminishes the hydrophobicity of
the ﬁrst TMS of yeast Cox2, was required to achieve functional import
of this subunit into mitochondria in vivo [1]. The W56R mutation was
originally numbered according to the Cox2 precursor that contained
the 15-residue leader sequence, so it actually corresponds to W41R in
the sequence of the mature Cox2.The mutation is located in a region
of the TMS close to the face of the inner mitochondrial membrane ex-
posed to the mitochondrial matrix and in close proximity to Cox7a
(Fig. 7). All cytosol-expressed Cox2 subunits that are imported into mi-
tochondria exhibit, in average, diminished hydrophobicity of the ﬁrst
TMS and a slightly increased hydrophobicity in the second TMS [70].
The lower average hydrophobicity of the ﬁrst TMS would allow its
full translocation to the mitochondrial matrix through the Tim23translocon, while the second TMSwould be retained by Tim23 and later-
ally inserted into the inner mitochondrial membrane [55]. These changes
in the average hydrophobicity of the two TMS of a cytosol-synthesized
Cox2 ensures the proper insertion of this subunit in the inner mitochon-
drial membrane in order to reach its characteristic topology, with both
the N- and C-termini exposed towards the IMS.
Mutations that diminish hydrophobicity in a TMS may allow im-
port of the corresponding protein into mitochondria, but at the
same time, they may affect the assembly of the subunit, or its stabili-
ty, or even abolish the function of the whole complex. In the case of
the allotopically-expressed Cox2W56R, the oxygen uptake of CcOW56R
in the presence of cytochrome c is not severely impaired, since only
20–25% of the oxygen-uptake activity was lost. The CcOW56R contains
an arginine with a positive charge that substitutes a tryptophan that
is exposed towards Leucine 24 in Cox7a, according to a model built
with the yeast CcO subunits based on the bovine CcO crystallographic
structure (Fig. 7). Since a charged residue is not expected to interact
in an hydrophobic milieu, the presence of R56 may induce some con-
formational changes that may diminish the activity of the enzyme.
More importantly, 40% lower accumulation levels of CcOW56R were
observed in the Δcox2+Cox2W56R transformant. We suggest that
the import, maturation or assembly of CcOW56R into CcO is a
rate-limiting process, and/or that a fraction of the
allotopically-expressed Cox2W56R precursor that reaches the inner
mitochondrial membrane may be degraded by mitochondrial prote-
ases before it is matured or before it gets functionally assembled
into CcO. Notwithstanding the reduced levels of CcOW56R, these are
enough to sustain growth rates of the Δcox2+Cox2W56R transfor-
mant in liquid media containing non-fermentable carbon sources,
albeit at slightly lower rates than those of the WT strain.
CcO assembly is a linear process, the ﬁrst assembly intermediate is
the Cox1 subunit, and the rest of the subunits and cofactors are
thought to be added in a sequential order [52,71]. In mutants where
CcO assembly is blocked, most of the subunits are rapidly degraded,
but also the synthesis of Cox1 is down-regulated, and this process de-
pends on the Cox1 carboxyl-terminal end [72–74]. The regulation of
the Cox1 synthesis prevents the formation of a pro-oxidant interme-
diates containing unassembled heme a3 [75]. As expected, Cox1 syn-
thesis was decreased in the Δcox2 mutant as compared to the WT
strain. Nevertheless, in the presence of the allotopically-expressed
Cox2W56R, mitochondrial Cox1 synthesis was restored to normal
levels. This indicates that the presence of Cox2 in the inner mitochon-
drial membrane, independently of its origin (mitochondrion- or
cytosol-synthesized), allows for a normal Cox1 synthesis in the or-
ganelle. In addition, pulse-chase experiments suggest that the newly
synthesized Cox1 subunit in the complemented strain is stable
for several hours, indicating that Cox1 is being incorporated correctly
into the inner mitochondrial membrane when adequate steady-state
levels of the allotopically-expressed Cox2W56R are present. This ob-
servation strongly supports that the W56R mutation present in
Cox2 does not impair the CcO biogenesis, however we cannot rule
out a possible interference of the W56R mutation in the assembly of
Cox2 to the enzyme.
Two supercomplexes involving CcO (III2IV2 and III2IV1) have been
previously identiﬁed and characterized in yeast [76–80]. Two additional
protein components, Rcf1 and Rcf2, that seem to be critical in
maintaining the interaction between CcO and the bc1 complex in
these supercomplexes, were recently described [81–83]. Here, carrying
BN-PAGE in the presence of digitonin, we obtained data that suggest
that less supercomplexes containing CcO are accumulated in the
Δcox2+Cox2W56R transformant as compared to the WT strain. Since
CcO seems to be accumulating 40% less efﬁciently in the Δcox2+
Cox2W56R transformant, this mutant may also tend to assemble less
supercomplexes. Alternatively, the W56R mutation may somehow de-
stabilize the CcO-bc1 interactions in the supercomplexes and favor its
dissociation in the presence of digitonin.
2138 V. Cruz-Torres et al. / Biochimica et Biophysica Acta 1817 (2012) 2128–2139Pulse-labeling of mitochondrial proteins in vivowith [35S] methio-
nine also indicated the absence of a mitochondrion-synthesized
Cox2W56R. This observation discards the possibility of a highly im-
probable reversion that would restore the integrity of the interrupted
mitochondrial COX2 gene and therefore reactivate Cox2WT synthesis
inside mitochondria. Among others, this kind of experiments, are in-
dispensable to assess a successful allotopic expression [84]. False pos-
itives may arise due to reversions of the original mutations in the
mitochondrial genes, especially when single-point mutations are in-
volved, as in the case of several mitochondrial mutations described
in human patients (http://www.mitomap.org/MITOMAP).
As mentioned above, allotopic expression is an experimental strat-
egy upon which gene therapies against human mitochondrial dis-
eases may be developed, and it may be based on either the import
of cytosol-synthesized proteins [65,85] or as recently demonstrated,
on the import of its corresponding RNAs [86]. However, the ﬁeld of
allotopic expression of human mitochondrial genes is debatable
[18]. While several groups have provided promising evidence for
the allotopic expression of several integral membrane proteins
[87–92], others have failed to observe functional integration of
cytosol-synthesized membrane-embedded proteins [64,66,84,93].
Here, using yeast as a model system, we have provided unambiguous
biochemical evidence for the functional assembly of a cytosol-
synthesized Cox2 subunit into CcO, and provided information on the
maturation process that the corresponding precursor underwent dur-
ing its import into mitochondria. To our knowledge, this is the ﬁrst
biochemical characterization of a mitochondrial OXPHOS complex
carrying an allotopically-expressed subunit with two TMS.
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